David Rescott

Stock Analyst at Baird

(3.51)
# 855
Out of 4,893 analysts
61
Total ratings
56%
Success rate
4.09%
Average return

Stocks Rated by David Rescott

Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $78.17
Upside: +11.30%
Medtronic
May 22, 2025
Maintains: Neutral
Price Target: $94$92
Current: $89.40
Upside: +2.91%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55$61
Current: $46.78
Upside: +30.40%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$110
Current: $95.13
Upside: +15.63%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $315$330
Current: $243.87
Upside: +35.32%
Edwards Lifesciences
Apr 24, 2025
Maintains: Neutral
Price Target: $72$75
Current: $78.80
Upside: -4.82%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $115$120
Current: $103.86
Upside: +15.54%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600$575
Current: $526.05
Upside: +9.31%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25$26
Current: $18.80
Upside: +38.30%